Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIR Fluorescence Guided Thoracic Surgery Using ICG
NCT02611245Phase 1Completed
- Sponsor
- Chinese Academy of Sciences
- Start
- Aug 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in lung cancer and esophageal cancer, sponsored by Chinese Academy of Sciences. Primary endpoint: Detection rates of lung nodes with fluorescence imaging at 1 year. Started Aug 2015; status: completed.
02
Drugs
indocyanine green
03
Conditions
lung canceresophageal cancer
Beyond the preview
Go deeper on NCT02611245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611245.